53BP1 suppresses tumor growth and promotes susceptibility to apoptosis of ovarian cancer cells through modulation of the Akt pathway

Hong,Shuhui; Li,Xiaoyan; Zhao,Ying; Yang,Qifeng; Kong,Beihua

doi:10.3892/or.2012.1641

53BP1 suppresses tumor growth and promotes susceptibility to apoptosis of ovarian cancer cells through modulation of the Akt pathway

Authors:
- Shuhui Hong
- Xiaoyan Li
- Ying Zhao
- Qifeng Yang
- Beihua Kong
View Affiliations

Affiliations: Department of Obstetrics and Gynecology, Qilu Hospital, Shandong University, Ji'nan, Shandong 250012, P.R. China, Department of Obstetrics and Gynecology, Qilu Hospital, Shandong University, 107 Wenhuaxi Road, Ji'nan, Shandong 250012, P.R. China
Published online on: January 18, 2012 https://doi.org/10.3892/or.2012.1641
Pages: 1251-1257

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

53BP1 has been extensively studied as a key component of the DNA damage response, but little is known regarding the role of 53BP1 in preventing tumor development. The present study was designed to assess the impact of the modification of 53BP1 gene expression on the biological behavior of ovarian cancer cell lines and to elucidate the cellular pathway(s) triggered by 53BP1 in cancer cells. DNA liposome transfection technology was employed to increase and to knock down the expression of 53BP1 in A2780 and HO-8910PM cells, respectively. Viability, clonogenicity and cell cycle profiles were evaluated. Cell apoptosis was analyzed using flow cytometric assay. The expression of proteins related to apoptosis and cell signal transduction was assessed using western blotting. Increased expression of 53BP1 decreased the viability and the clonogenicity, and induced G2/M arrest and apoptosis of the treated cells. The protein expression of Bax, P21 and caspase-3 was upregulated, while the levels of Bcl-2 and p-Akt were reduced to a statistically significant level. In contrast, deregulation of 53BP1 significantly increased proliferative ability. Collectively, our data suggest that 53BP1 is involved in several important steps in controlling cell proliferation and growth and preventing tumor development.

View Figures

View References

1	Wright JW, Pejovic T, Jurevic L, Bishop CV, Hobbs T and Stouffer RL: Ovarian surface epitheliectomy in the non-human primate: continued cyclic ovarian function and limited epithelial replacement. Hum Reprod. 26:1422–1430. 2011. View Article : Google Scholar
2	Ovarian cancer: screening, treatment, and followup. NIH Consens Statement. 12:1–30. 1994.
3	Fong MY, McDunn J and Kakar SS: Identification of metabolites in the normal ovary and their transformation in primary and metastatic ovarian cancer. PLoS One. 6:e199632011. View Article : Google Scholar : PubMed/NCBI
4	Altomare DA, Menges CW, Xu J, et al: Losses of both products of the cdkn2a/arf locus contribute to asbestos-induced mesothelioma development and cooperate to accelerate tumorigenesis. PLoS One. 6:e188282011. View Article : Google Scholar : PubMed/NCBI
5	Iwabuchi K, Bartel PL, Li B, Marraccino R and Fields S: Two cellular proteins that bind to wild-type but not mutant p53. Proc Natl Acad Sci USA. 91:6098–6102. 1994. View Article : Google Scholar : PubMed/NCBI
6	Lowndes NF: The interplay between BRCA1 and 53BP1 influences death, aging, senescence and cancer. DNA Repair (Amst). 9:1112–1116. 2010. View Article : Google Scholar : PubMed/NCBI
7	Mochan TA, Venere M, DiTullio RA and Halazonetis TD: 53BP1 and NFBD1/MDC1-Nbs1 function in parallel interacting pathways activating ataxia-telangiectasia mutated (ATM) in response to DNA damage. Cancer Res. 63:8586–8591. 2003.PubMed/NCBI
8	Cescutti R, Negrini S, Kohzaki M and Halazonetis TD: TopBP1 functions with 53BP1 in the G1 DNA damage checkpoint. EMBO J. 29:3723–3732. 2010. View Article : Google Scholar : PubMed/NCBI
9	Wu PP, Chung HW, Liu KC, et al: Diallyl sulfide induces cell cycle arrest and apoptosis in HeLa human cervical cancer cells through the p53, caspase- and mitochondria-dependent pathways. Int J Oncol. 38:1605–1613. 2011.PubMed/NCBI
10	Iwabuchi K, Matsui T, Hashimoto M, Matsumoto Y, Kurihara T and Date T: Characterization of a cancer cell line that expresses a splicing variant form of 53BP1: separation of checkpoint and repair functions in 53BP1. Biochem Biophys Res Commun. 376:509–513. 2008. View Article : Google Scholar : PubMed/NCBI
11	Bartkova J, Horejsi Z, Sehested M, et al: DNA damage response mediators MDC1 and 53BP1: constitutive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumours. Oncogene. 26:7414–7422. 2007. View Article : Google Scholar : PubMed/NCBI
12	Shenhua X, Lijuan Q, Hanzhou N, et al: Establishment of a highly metastatic human ovarian cancer cell line (HO-8910PM) and its characterization. J Exp Clin Cancer Res. 18:233–239. 1999.PubMed/NCBI
13	Takeyama K, Monti S, Manis JP, et al: Integrative analysis reveals 53BP1 copy loss and decreased expression in a subset of human diffuse large B-cell lymphomas. Oncogene. 27:318–322. 2008. View Article : Google Scholar : PubMed/NCBI
14	Nuciforo PG, Luise C, Capra M, Pelosi G and d’Adda di Fagagna F: Complex engagement of DNA damage response pathways in human cancer and in lung tumor progression. Carcinogenesis. 28:2082–2088. 2007. View Article : Google Scholar : PubMed/NCBI
15	Du RZH, Chen J and Jiang ZM: Relationship between loss of 53BP1 expression and clinical pathology in prostate adenocarcinoma. Chin J Clin Exp Pathol. 1:44–47. 2011.
16	Ward IM, Difilippantonio S, Minn K, et al: 53BP1 cooperates with p53 and functions as a haploinsufficient tumor suppressor in mice. Mol Cell Biol. 25:10079–10086. 2005. View Article : Google Scholar : PubMed/NCBI
17	Dai RY, Chen SK, Yan DM, et al: PI3K/Akt promotes GRP78 accumulation and inhibits endoplasmic reticulum stress-induced apoptosis in HEK293 cells. Folia Biol (Praha). 56:37–46. 2010.PubMed/NCBI
18	Miao B, Skidan I, Yang J, et al: Small molecule inhibition of phosphatidylinositol-3,4,5-triphosphate (PIP3) binding to pleckstrin homology domains. Proc Natl Acad Sci USA. 107:20126–20131. 2010. View Article : Google Scholar : PubMed/NCBI
19	Franke TF, Yang SI, Chan TO, et al: The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell. 81:727–736. 1995. View Article : Google Scholar : PubMed/NCBI
20	Hemmings BA: PH domains - a universal membrane adapter. Science. 275:18991997. View Article : Google Scholar : PubMed/NCBI
21	Hemmings BA: PtdIns(3,4,5)P3 gets its message across. Science. 277:5341997. View Article : Google Scholar : PubMed/NCBI
22	Xu X, Zhang Y, Qu D, Jiang T and Li S: Osthole induces G2/M arrest and apoptosis in lung cancer A549 cells by modulating PI3K/Akt pathway. J Exp Clin Cancer Res. 30:332011. View Article : Google Scholar : PubMed/NCBI
23	Lee DH, Thoennissen NH, Goff C, et al: Synergistic effect of low-dose cucurbitacin B and low-dose methotrexate for treatment of human osteosarcoma. Cancer Lett. 306:161–170. 2011. View Article : Google Scholar : PubMed/NCBI
24	Yingchun L, Xiujuan Q, Jinglei Q, et al: E3 ubiquitin ligase Cbl-b potentiates the apoptotic action of arsenic trioxide by inhibiting the PI3K/Akt pathway. Braz J Med Biol Res. 44:105–111. 2011. View Article : Google Scholar : PubMed/NCBI
25	Kucharzewska P, Welch JE, Svensson KJ and Belting M: The polyamines regulate endothelial cell survival during hypoxic stress through PI3K/AKT and MCL-1. Biochem Biophys Res Commun. 380:413–418. 2009. View Article : Google Scholar : PubMed/NCBI
26	Zhang F, Zheng W, Pi R, et al: Cryptotanshinone protects primary rat cortical neurons from glutamate-induced neurotoxicity via the activation of the phosphatidylinositol 3-kinase/Akt signaling pathway. Exp Brain Res. 193:109–118. 2009. View Article : Google Scholar : PubMed/NCBI
27	Rondelet B, Dewachter C and Kerbaul F: et al Prolonged overcirculation-induced pulmonary arterial hypertension as a cause of right ventricular failure. Eur Heart J. May 23–2011.(E-pub ahead of print).
28	Davies MA, Koul D, Dhesi H, et al: Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN. Cancer Res. 59:2551–2556. 1999.PubMed/NCBI
29	Cardone MH, Roy N, Stennicke HR, et al: Regulation of cell death protease caspase-9 by phosphorylation. Science. 282:1318–1321. 1998. View Article : Google Scholar : PubMed/NCBI
30	Liu W, Konduri SD, Bansal S, et al: Estrogen receptor-alpha binds p53 tumor suppressor protein directly and represses its function. J Biol Chem. 281:9837–9840. 2006. View Article : Google Scholar : PubMed/NCBI
31	Pestell RG, Albanese C, Reutens AT, Segall JE, Lee RJ and Arnold A: The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr Rev. 20:501–534. 1999.PubMed/NCBI
32	Shin SY, Kim CG, Kim SH, Kim YS, Lim Y and Lee YH: Chlorpromazine activates p21^Waf1/Cip1 gene transcription via early growth response-1 (Egr-1) in C6 glioma cells. Exp Mol Med. 42:395–405. 2010.PubMed/NCBI
33	Zhou BP, Liao Y, Xia W, Spohn B, Lee MH and Hung MC: Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol. 3:245–252. 2001. View Article : Google Scholar : PubMed/NCBI